Q2 2026 Holdings
Filed 2026-08-14 | 15 holdings | $750.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $287.7M | 8,490,353 | 38.3% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $115.6M | 3,226,400 | 15.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $85.5M | 3,848,256 | 11.4% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $75.8M | 4,117,354 | 10.1% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $63.5M | 2,441,000 | 8.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $31.1M | 2,808,368 | 4.1% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $30.2M | 1,677,852 | 4.0% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $28.8M | 4,053,775 | 3.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $16.7M | 9,632,561 | 2.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $14.7M | 3,468,430 | 2.0% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $834.4K | 2,878,148 | 0.1% |